In support of this notion, elevated expression of ST6Gal1 concurrently activated EGFR in the pancreatic cancer cell line Suit2, exhibiting higher invasion and elevated levels of mesenchymal markers (Britain et al., 2021). Here, ST6GAL1 is linked to familial pancreatic carcinoma.